A detailed history of Requisite Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Requisite Capital Management, LLC holds 508 shares of LLY stock, worth $412,028. This represents 0.09% of its overall portfolio holdings.

Number of Shares
508
Previous 464 9.48%
Holding current value
$412,028
Previous $411,000 4.62%
% of portfolio
0.09%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025

BUY
$727.2 - $932.06 $31,996 - $41,010
44 Added 9.48%
508 $392,000
Q2 2024

Aug 02, 2024

SELL
$724.87 - $909.04 $605,991 - $759,957
-836 Reduced 64.31%
464 $420,000
Q3 2023

Nov 01, 2023

BUY
$434.7 - $599.3 $565,110 - $779,089
1,300 New
1,300 $698,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $771B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Requisite Capital Management, LLC Portfolio

Follow Requisite Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Requisite Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Requisite Capital Management, LLC with notifications on news.